Total Medical devices industry deals worth $5.3bn were announced globally for June 2022, with the $1bn acquisition of MediFox DAN Group being the sector’s biggest investment, according to GlobalData’s deals database.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 116.9% over the previous month of $2.43bn and a drop of 57.6% when compared with the last 12-month average of $12.42bn.
In terms of number of deals, the sector saw a drop of 6.00% with 188 deals in June 2022 when compared to the last 12-month average of 200 deals.
In value terms, Europe led the activity with deals worth $2.18bn in June 2022.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataMedical devices industry deals in June 2022: Top deals
The top five deals accounted for 57.3% of the overall value during June 2022.
The combined value of the top five deals stood at $3.02bn, against the overall value of $5.3bn recorded for the month.
The top five Medical devices industry deals of June 2022 tracked by GlobalData were:
1) ResMed $1bn acquisition deal with MediFox DAN Group
2) The $797.86m private equity of SPT Labtech by EQT IX Fund
3) Fleury $534.27m acquisition deal with Instituto Hermes Pardini
4) The $462m acquisition of Implantable Provider Group by Evolent Health
5) Boston Scientific $230m acquisition deal with M.I.Tech
